Biomark Diagnostics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 11, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	41	16	18	11	13	24
Market Cap Growth	249.56%	-15.13%	60.82%	-9.22%	-48.38%	157.32%
Enterprise Value	41	17	19	13	14	25
Last Close Price	0.37	0.18	0.22	0.14	0.17	0.33
PS Ratio	467.21	145.04	152.12	100.50	356.91	-
PB Ratio	66.78	12.85	-40.73	-13.42	-24.67	-386.98
P/TBV Ratio	66.78	12.85	-	-	-	-
EV/Sales Ratio	-	154.52	161.35	110.73	393.16	-
Debt / Equity Ratio	0.93	0.64	-2.54	-1.44	-3.09	-12.70
Asset Turnover	0.09	0.07	0.18	0.14	0.04	-
Quick Ratio	1.73	2.14	0.16	0.06	0.31	0.98
Current Ratio	1.73	2.14	0.16	0.08	0.33	1.00
Return on Equity (ROE)	-	-340.70%	-	-	-	-
Return on Assets (ROA)	-79.14%	-60.59%	-117.29%	-104.38%	-66.20%	-80.77%
Return on Capital Employed (ROCE)	-197.50%	-107.60%	1099.30%	197.40%	4328.70%	-3366.60%
Earnings Yield	-2.87%	-8.62%	-5.75%	-11.94%	-9.27%	-3.57%
FCF Yield	-2.46%	-4.90%	-3.98%	-5.96%	-8.06%	-2.64%
Buyback Yield / Dilution	-10.10%	-6.67%	-2.97%	-6.22%	-6.31%	-2.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.